PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branch Retinal Vein Occlusion

التفاصيل البيبلوغرافية
العنوان: PSS26 The Use of A Mixed-Treatment Comparison to Assess the Cost-Effectiveness of Ozurdex® (Dexamethasone Intravitreal Implant in Applicator) Compared With Bevacizumab Intravitreal Injections for Patients With Macular Oedema Following Branch Retinal Vein Occlusion
المؤلفون: N.J. Brereton, C. Almond, E. Hayward, Nick Freemantle
المصدر: Value in Health. 14(7)
بيانات النشر: Elsevier BV, 2011.
سنة النشر: 2011
مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, business.industry, Cost effectiveness, Health Policy, Treatment comparison, Public Health, Environmental and Occupational Health, Macular oedema, medicine.disease, Surgery, Ophthalmology, Dexamethasone Intravitreal Implant, Medicine, Branch retinal vein occlusion, business, medicine.drug
تدمد: 1098-3015
DOI: 10.1016/j.jval.2011.08.1491
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f06ca60a2c0ef6c869064cbdc6775af
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....3f06ca60a2c0ef6c869064cbdc6775af
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10983015
DOI:10.1016/j.jval.2011.08.1491